Daria Stypinski

Statistics

Publications

Citations

658

H-Index

Active since

1996

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Celerion (United States)

University of Alberta

Pfizer (United States)

Novartis (Switzerland)

Daria Stypinski is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, pharmacokinetics, and clinical pharmacology.

Publications per year

1996–2020

Publications

Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A

Thomayant Prueksaritanont, DA Tatosian, Xiaoyan Chu et al. · Clinical Pharmacology & Therapeutics · 2016 · 139 citations

Medicine, Pharmacokinetics, Pharmacology +14

Drug Interactions with Colesevelam Hydrochloride, a Novel, Potent Lipid-Lowering Agent

Joanne M. Donovan, Daria Stypinski, Mark R. Stiles et al. · Cardiovascular Drugs and Therapy · 2000 · 93 citations

Pharmacy, Pharmacology, Pharmacotherapy +8

Pharmacokinetics and electrocardiographic pharmacodynamics of artemether‐lumefantrine (Riamet<sup>®</sup>) with concomitant administration of ketoconazole in healthy subjects

Gilbert Lefèvre, Polly Carpenter, C. Souppart et al. · British Journal of Clinical Pharmacology · 2002 · 83 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Fluoroazomycin arabinoside (FAZA): synthesis,2H and3H-labelling and preliminary biological evaluation of a novel 2-nitroimidazole marker of tissue hypoxia

Piyush Kumar, Daria Stypinski, Hong Jun Xia et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 1999 · 75 citations

Medicine, Oncology, Pharmacology +14

A Contract Research Organization's Response to the New FDA Guidances for Bioequivalence/Bioavailability Studies for Orally Administered Drug Products

Ebi K. Kimanani, Daria Stypinski, Gary Curtis et al. · The Journal of Clinical Pharmacology · 2000 · 48 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

1–5 of 16